Overdose Deaths Are Down 12%, and the CDC Just Built a Dashboard to Prove It. Good. Now Fix What It Can't See.
A new federal data channel puts the decline on one page. It also shows how little a single national number says about your block.
On International Overdose Awareness Day, August 31, the CDC launched an Overdose Prevention Data Channel and led with a number: 67,798 predicted overdose deaths in the 12 months ending March 2026, 12.3% fewer than the year before.
A falling number is not a safe supply, and the dashboard is only as honest as the people reading it.
The newest update, on October 14, puts the 12 months ending May 2026 at 66,478 deaths, about 11.5% below a year earlier. That is a long way down from 2021 to 2023, when the country lost more than 105,000 people a year, and the people who say naloxone, medications and expanded access did much of the work have evidence on their side. Brown University epidemiologist Brandon Marshall told STAT it is “unprecedented to see overdose deaths come down so dramatically, so quickly.” In the same breath he added: “we’re nowhere near out of this crisis.”
The slowdown is the part to read twice. The same Medical Daily report shows New York’s decline shrinking to about 8% in the latest year, far slower than the two-year fall before it. The CDC’s own Grant Baldwin, who runs its Division of Overdose Prevention, put it more carefully than any headline: “The continued decline in predicted overdose deaths is encouraging, but progress is not a finish line.” And the CDC labels recent counts as incomplete, so the newest months will be revised.
If you are in recovery, or you love someone who is not, the national number is the least useful one on the page. It does not know your county, your supply, or the sedative that showed up in it last spring. A dashboard that lets a provider see their own county’s trend this month, not last year, is worth more than any press release.
For case managers and facility staff, the move is to bookmark the channel and pull your own state and county line before your next team meeting. Ask what changed, and ask who is not in the data. Deaths are the count. The people who survived are the reason for the work.
Sources Cited
- 01.A
- 02.B
- 03.B
Filed Under
trendspolicyOverdoseGovernment DataFentanylNaloxone
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
A Breakthrough Badge Isn't a Treatment. Meth Patients Need the One That Already Works.
NET Recovery's device got FDA Breakthrough designation for stimulant use disorder on Sept. 23. What that does and doesn't mean, and what clinics can offer today.
Technology & InnovationArizona Built an AI Front Door for Opioid Treatment. It Inherited the Same Broken Directory.
AHCCCS, Google Public Sector, and Syntasa launched a generative-AI opioid treatment locator for Arizona. The federal locator it's meant to improve on has a documented history of stale data and dead ends — the question is whether a chatbot fixes that or just says it faster.
Technology & InnovationNo Drug Treats Stimulant Addiction Yet. The FDA Just Fast-Tracked a Device That Might.
FDA granted Breakthrough Device Designation to a transcutaneous stimulation device for stimulant use disorder — a category where no medication is FDA-approved and no device was previously FDA-cleared.